As of 2025-07-03, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -15.14 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.64 USD, the upside of Cullinan Oncology Inc is -298.23%.
Based on its market price of 7.64 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 298.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.14 - -15.14 | -15.14 | -298.23% |
| P/E | (74.09) - (87.05) | (88.14) | -1253.7% |
| DDM - Stable | (14.81) - (34.95) | (24.88) | -425.6% |
| DDM - Multi | (10.19) - (19.55) | (13.48) | -276.5% |
| Market Cap (mil) | 450.84 |
| Beta | 0.71 |
| Outstanding shares (mil) | 59.01 |
| Enterprise Value (mil) | 374.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 15.06% |
| Cost of Debt | 5.00% |
| WACC | 9.99% |